AACR Statement on the Defeat of Proposition 29 – The California Cancer Research Act
WASHINGTON, D.C. — The American Association for Cancer Research is profoundly disappointed by the narrow defeat of Proposition 29, The California Cancer Research Act, which it regards as a missed opportunity to save lives from death and disease caused by tobacco use.
Tobacco use is the leading preventable cause of premature death in the United States and is responsible for 18 different cancers and nearly a third of all cancer deaths. The single most impactful measure we could take to prevent people from dying from cancer is simply to prevent them from using tobacco in the first place, and by increasing the cost of cigarettes, which is what Proposition 29 would have helped achieve.
The AACR nonetheless applauds the passionate commitment of the many organizations and individuals who worked tirelessly to raise awareness about tobacco’s toll and who built a tremendous level of support for Proposition 29. The AACR is confident that the momentum to combat tobacco use will not stop with the June 5 vote and hopes that states across the nation will be inspired to consider similar anti-tobacco measures.
About the AACR
Founded in 1907, the American Association for Cancer Research (AACR) is the world’s first and largest professional organization dedicated to advancing cancer research and its mission to prevent and cure cancer. AACR’s membership includes 34,000 laboratory, translational and clinical researchers; population scientists; other health care professionals; and cancer advocates residing in more than 90 countries. The AACR marshals the full spectrum of expertise of the cancer community to accelerate progress in the prevention, biology, diagnosis and treatment of cancer by annually convening more than 20 conferences and educational workshops, the largest of which is the AACR Annual Meeting with more than 17,000 attendees. In addition, the AACR publishes seven peer-reviewed scientific journals and a magazine for cancer survivors, patients and their caregivers. The AACR funds meritorious research directly as well as in cooperation with numerous cancer organizations. As the Scientific Partner of Stand Up To Cancer, the AACR provides expert peer review, grants administration and scientific oversight of individual and team science grants in cancer research that have the potential for near-term patient benefit. The AACR actively communicates with legislators and policymakers about the value of cancer research and related biomedical science in saving lives from cancer.
For more information about the AACR, visit www.AACR.org.